WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (Nasdaq: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics (TM), today announced that Alan A. Musso, Vice President and Chief Financial Officer, is scheduled to present at the Cowen and Company 28th Annual Health Care Conference at The Boston Marriott Copley Place on Tuesday, March 18, 2008, at 10:15 a.m. Eastern Daylight Time.
